Back to Search
Start Over
976P Phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): Registrational data from DESTINY-Lung01
- Source :
- Annals of Oncology. 33:S995-S996
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........a56be7b8d8a766f09d24ddbbc10bc8b1
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1104